Skip to Main Content

Paper Details

Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis.
Clin Transl Radiat Oncol
0
2021
androgen, cancer, non-metastatic prostate, patient, patients, prostate cancer
Author NameAffiliation
Gerald L AndrioleWashington University School of Medicine
Jeff M MichalskiWashington University School of Medicine
  • 1 - 2

Datasets

Release 1.2